A Randomized, Controlled, Multicenter Trial of Filgrastim (Recombinant-Methionyl Human Granulocyte Colony Stimulating Factor; G-CSF) for the Prevention of Grade 4 Neutropenia in Patients With HIV Infection.
Clinical trial NCT00002126 · COMPLETED
Trial details
- NCT number
- NCT00002126
- Sponsor
- Amgen
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Enrollment
- 250
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.